A Phase III trial of fludarabine, cyclophosphamide, and rituximab vs. pentostatin, cyclophosphamide, and rituximab in B-cell chronic lymphocytic leukemia
Reynolds, Craig, Di Bella, Nicholas, Lyons, Roger M., Hyman, William, Richards, Donald A., Robbins, Gerald J., Vellek, Mark, Boehm, Kristi A., Zhan, Feng, Asmar, Lina
Published in Investigational new drugs (01.06.2012)
Published in Investigational new drugs (01.06.2012)
Get full text
Journal Article
Rapid Prospective Identification of Non-Germinal Center B Cell-Like (GCB) Diffuse Large B-Cell Lymphoma (DLBCL) Patients for Targeted Trials: Early Results From PYRAMID, A Phase 2 Randomized Study of R-CHOP ± Bortezomib In Newly Diagnosed Non-GCB DLBCL
Doner, Kevin, Flinn, Ian W., Ulrich, Brian K., Noga, Stephen J., Chowhan, Naveed M., Papish, Steven W., Mahmood, Tallat, Reeves, James A, Bella, Nicholas J. Di, Robbins, Gerald J., Ramchandren, Radhakrishnan, Aung, Sein, Lawler, William, Parasuraman, Sudha, Corvez, Maria M., Mulligan, George, Leonard, John P.
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article
Phase III Trial of Fludarabine, Cyclophosphamide, and Rituximab Vs. Pentostatin, Cyclophosphamide, and Rituximab in B-Cell Chronic Lymphocytic Leukemia
Reynolds, Craig, Di Bella, Nicholas, Lyons, Roger M., Hyman, William J, Lee, Gary L., Richards, Donald A, Robbins, Gerald J., Vellek, Mark, Boehm, Kristi A, Zhan, Feng, Asmar, Lina
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article